US20030109503A1
(en)
*
|
1995-06-06 |
2003-06-12 |
Smithkline Beecham P.L.C. |
Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
|
IT1295271B1
(it)
*
|
1997-10-03 |
1999-05-04 |
Chiesi Farma Spa |
Monolita contenente uno o piu'farmaci costituito da tre strati a meccanismo di rilascio differenziato
|
KR100630290B1
(ko)
*
|
1998-05-15 |
2006-09-29 |
쥬가이 세이야쿠 가부시키가이샤 |
방출제어제제
|
EP1005863A1
(en)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
US6432448B1
(en)
|
1999-02-08 |
2002-08-13 |
Fmc Corporation |
Edible coating composition
|
US6723342B1
(en)
|
1999-02-08 |
2004-04-20 |
Fmc Corporation |
Edible coating composition
|
US6294199B1
(en)
|
1999-04-13 |
2001-09-25 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising administering amoxycillin
|
US6878386B1
(en)
|
1999-04-13 |
2005-04-12 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
|
US7250176B1
(en)
*
|
1999-04-13 |
2007-07-31 |
Beecham Pharmaceuticals (Pte) Limited |
Method of treating a bacterial infection
|
DE19927688A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
DE19954421A1
(de)
*
|
1999-11-12 |
2001-05-31 |
Lohmann Therapie Syst Lts |
Filmförmige Zubereitung zur biphasigen Freisetzung pharmakologisch wirksamer oder anderer Substanzen
|
EP1253976A2
(en)
*
|
2000-01-25 |
2002-11-06 |
The Victoria University Of Manchester |
Delayed release of fluids
|
FR2805462B1
(fr)
*
|
2000-02-24 |
2003-08-15 |
Therabel Res |
Nouvelle forme galenique orale a liberation prolongee de la molsidomine
|
AR030557A1
(es)
|
2000-04-14 |
2003-08-27 |
Jagotec Ag |
Una tableta en multicapa de liberacion controlada y metodo de tratamiento
|
US6756057B2
(en)
|
2000-10-12 |
2004-06-29 |
Beecham Pharmaceuticals (Pte) Limited |
Amoxicillin and potassium clavulanate dosage form
|
EP1330236A2
(en)
|
2000-10-12 |
2003-07-30 |
Beecham Pharmaceuticals (Pte) Limited |
Formulation containing amoxicillin
|
BR0115585A
(pt)
|
2000-11-28 |
2005-12-13 |
Fmc Corp |
Composições de revestimento de pronta liberação, endurecìvel, comestìvel, seca e, úmida, forma de dosagem sólida, e, método para revestir uma forma de dosagem sólida farmacêutica ou veterinária, confeito, semente, ração animal, fertilizante, comprimido de pesticida ou alimento
|
AU2008255254B2
(en)
*
|
2001-03-31 |
2010-12-09 |
Jagotec Ag |
A pharmaceutical tablet system that floats on gastric fluid for multipulse release of active substance and respective processes of producing same and a cup-shaped envelope of same
|
EP1245227A1
(en)
*
|
2001-03-31 |
2002-10-02 |
Jagotec Ag |
A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
|
US7211267B2
(en)
|
2001-04-05 |
2007-05-01 |
Collagenex Pharmaceuticals, Inc. |
Methods of treating acne
|
US20030070584A1
(en)
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US20040137062A1
(en)
*
|
2001-05-25 |
2004-07-15 |
Sham Chopra |
Chronotherapy tablet and methods related thereto
|
IL159812A0
(en)
*
|
2001-07-12 |
2004-06-20 |
Teva Pharma |
Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester in a controlled release core
|
IL159813A0
(en)
*
|
2001-07-12 |
2004-06-20 |
Teva Pharma |
Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core
|
MXPA04002980A
(es)
*
|
2001-09-28 |
2005-06-20 |
Johnson & Johnson |
Formas de dosificacion que tienen un nucleo interior y coraza exterior con diferentes formas.
|
US7217381B2
(en)
|
2001-09-28 |
2007-05-15 |
Mcneil-Ppc, Inc. |
Systems, methods and apparatuses for manufacturing dosage forms
|
US7122143B2
(en)
|
2001-09-28 |
2006-10-17 |
Mcneil-Ppc, Inc. |
Methods for manufacturing dosage forms
|
US6837696B2
(en)
|
2001-09-28 |
2005-01-04 |
Mcneil-Ppc, Inc. |
Apparatus for manufacturing dosage forms
|
US6982094B2
(en)
|
2001-09-28 |
2006-01-03 |
Mcneil-Ppc, Inc. |
Systems, methods and apparatuses for manufacturing dosage forms
|
US20040146559A1
(en)
*
|
2002-09-28 |
2004-07-29 |
Sowden Harry S. |
Dosage forms having an inner core and outer shell with different shapes
|
US20030228368A1
(en)
*
|
2001-09-28 |
2003-12-11 |
David Wynn |
Edible solid composition and dosage form
|
US7838026B2
(en)
|
2001-09-28 |
2010-11-23 |
Mcneil-Ppc, Inc. |
Burst-release polymer composition and dosage forms comprising the same
|
US8309118B2
(en)
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
US7126786B1
(en)
*
|
2001-10-01 |
2006-10-24 |
Certance Llc |
Motor/encoder assembly for tape drives
|
WO2003042136A2
(en)
*
|
2001-11-13 |
2003-05-22 |
Teva Pharmaceutical Industries, Ltd. |
Process for the production of l-dopa ethyl ester
|
AU2002340470A1
(en)
|
2001-11-13 |
2003-05-26 |
Teva Pharmaceutical Industries, Ltd. |
L-dopa ethyl ester salts and uses thereof
|
ITMI20020514A1
(it)
*
|
2002-03-12 |
2003-09-12 |
Jagotec Ag |
Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
|
US7094427B2
(en)
*
|
2002-05-29 |
2006-08-22 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
US20030224045A1
(en)
*
|
2002-05-29 |
2003-12-04 |
Chien-Hsuan Han |
Combination immediate release sustained release levodopa/carbidopa dosage forms
|
US20040166159A1
(en)
*
|
2002-05-29 |
2004-08-26 |
Chien-Hsuan Han |
Pharmaceutical dosage forms having immediate and controlled release properties that contain an aromatic amino acid decarboxylase inhibitor and levodopa
|
US20060013875A1
(en)
*
|
2002-05-29 |
2006-01-19 |
Impax Laboratories, Inc. |
Combination immediate release controlled release levodopa/carbidopa dosage forms
|
PL193976B1
(pl)
*
|
2002-07-01 |
2007-04-30 |
Pliva Krakow |
Tabletka o przedłużonym działaniu zawierająca indapamid i sposób wytwarzania tabletki o przedłużonym działaniu zawierającej indapamid
|
US7807197B2
(en)
*
|
2002-09-28 |
2010-10-05 |
Mcneil-Ppc, Inc. |
Composite dosage forms having an inlaid portion
|
US20040081695A1
(en)
*
|
2002-09-28 |
2004-04-29 |
Sowden Harry S |
Dosage forms having an inner core and an outer shell
|
BR0314777A
(pt)
*
|
2002-09-28 |
2005-07-26 |
Mcneil Ppc Inc |
Formas de dosagem de liberação modificada
|
EP1449525A1
(en)
*
|
2003-02-20 |
2004-08-25 |
Cross Chem Llc |
chewing gum in the form of multi-layer tablets
|
EP1663175B1
(en)
*
|
2003-09-19 |
2012-03-28 |
Sun Pharma Advanced Research Company Limited |
Oral drug delivery system
|
US10213387B2
(en)
|
2003-09-19 |
2019-02-26 |
Sun Pharma Advanced Research Company Ltd. |
Oral drug delivery system
|
US10226428B2
(en)
|
2003-09-19 |
2019-03-12 |
Sun Pharma Advanced Research Company Ltd. |
Oral drug delivery system
|
AU2004296404A1
(en)
*
|
2003-12-09 |
2005-06-23 |
Spherics, Inc. |
Bioadhesive polymers with catechol functionality
|
US8007827B2
(en)
*
|
2004-04-02 |
2011-08-30 |
Impax Laboratories, Inc. |
Pharmaceutical dosage forms having immediate release and/or controlled release properties
|
US20050249782A1
(en)
*
|
2004-05-04 |
2005-11-10 |
Victor Perry |
Drug delivery device
|
US7329418B2
(en)
*
|
2004-05-21 |
2008-02-12 |
Accu Break Technologies, Inc. |
Pharmaceutical tablets having height greater than width
|
US7780985B2
(en)
*
|
2005-07-12 |
2010-08-24 |
Accu-Break Technologies, Inc. |
Tablets having a printed separation mark to guide breaking
|
US7838031B2
(en)
|
2004-05-21 |
2010-11-23 |
Lawrence Solomon |
Method of administering a partial dose using a segmented pharmaceutical tablet
|
US7713547B2
(en)
|
2004-05-21 |
2010-05-11 |
Accu-Break Pharmaceuticals, Inc. |
Method of administering a partial dose of a segmented pharmaceutical tablet
|
US7318935B2
(en)
*
|
2004-05-21 |
2008-01-15 |
Accu-Break Technologies, Inc. |
Pharmaceutical tablets with active and inactive segments
|
EP1755564B1
(en)
*
|
2004-05-21 |
2013-10-16 |
Accu-Break Technologies, Inc. |
Immediate release pharmaceutical tablets with height greater than width
|
US7622137B2
(en)
*
|
2004-05-21 |
2009-11-24 |
Accu-Break Technologies, Inc. |
Dosage forms contained within a capsule or sachet
|
US20060002986A1
(en)
*
|
2004-06-09 |
2006-01-05 |
Smithkline Beecham Corporation |
Pharmaceutical product
|
US20080311191A1
(en)
*
|
2004-08-27 |
2008-12-18 |
Avinash Nangia |
Multi-Layer Tablets and Bioadhesive Dosage Forms
|
DE102004043863A1
(de)
*
|
2004-09-10 |
2006-03-16 |
Nitec Pharma Ag |
Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
|
KR101363563B1
(ko)
*
|
2004-09-10 |
2014-02-14 |
자고텍 아게 |
활성성분의 부위 및 시간 제어적 위장관 방출 정제
|
DK1836665T3
(da)
|
2004-11-19 |
2013-04-15 |
Glaxosmithkline Llc |
Fremgangsmåde til specialtilpasset afgivelse af medikamentkombinationsprodukter med variabel dosis til individualisering af terapier
|
US8673352B2
(en)
|
2005-04-15 |
2014-03-18 |
Mcneil-Ppc, Inc. |
Modified release dosage form
|
KR100714616B1
(ko)
*
|
2005-06-23 |
2007-05-07 |
삼성전기주식회사 |
지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
|
EP1901720A2
(en)
*
|
2005-06-23 |
2008-03-26 |
Spherics, Inc. |
Improved dosage forms for movement disorder treatment
|
US10071060B2
(en)
|
2005-07-08 |
2018-09-11 |
Bioventures, Llc |
Asymmetrically coated table
|
WO2007058660A1
(en)
*
|
2005-11-18 |
2007-05-24 |
Accu-Break Technologies, Inc. |
Segmented pharmaceutical dosage forms
|
DE602006018529D1
(de)
|
2005-12-29 |
2011-01-05 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Mehrschichtige tablette mit dreifacher freisetzungskombination
|
EP2086515A2
(en)
*
|
2006-03-02 |
2009-08-12 |
Vaunnex, Inc. |
Rate-controlled bioadhesive oral dosage formulations
|
US20070237815A1
(en)
*
|
2006-04-06 |
2007-10-11 |
Lawrence Solomon |
Dosage forms and methods comprising amlodipine and chlorthalidone
|
JP5410964B2
(ja)
*
|
2006-05-23 |
2014-02-05 |
オラヘルス コーポレーション |
付着性アカシアゴムを含む二層構造の口腔内付着錠
|
US20070293587A1
(en)
*
|
2006-05-23 |
2007-12-20 |
Haley Jeffrey T |
Combating sinus, throat, and blood infections with xylitol delivered in the mouth
|
SG174026A1
(en)
|
2006-08-03 |
2011-09-29 |
Nitec Pharma Ag |
Delayed-release glucocorticoid treatment of rheumatoid disease
|
US20110086092A1
(en)
*
|
2006-08-08 |
2011-04-14 |
Accu-Break Technologies, Inc. |
Pharmacuetical tablets containing a plurality of active ingredients
|
MX2009002235A
(es)
*
|
2006-08-30 |
2009-03-13 |
Jagotec Ag |
Formulaciones de dosis oral, solidas, de liberacion controlada que comprenden nisoldipina.
|
WO2008079404A2
(en)
*
|
2006-12-22 |
2008-07-03 |
Combinatorx, Incorporated |
Pharmaceutical compositions for treatment of parkinson's disease and related disorders
|
WO2008142627A2
(en)
*
|
2007-05-17 |
2008-11-27 |
Ranbaxy Laboratories Limited |
Multilayered modified release formulation comprising amoxicillin and clavulanate
|
US8513323B2
(en)
*
|
2007-06-22 |
2013-08-20 |
Kimbery-Clark Worldwide, Inc. |
Multifunctional silicone blends
|
ES2692437T3
(es)
*
|
2007-08-13 |
2018-12-03 |
Abuse Deterrent Pharmaceutical Llc |
Fármacos resistentes al abuso, método de uso y método de preparación
|
KR101569604B1
(ko)
|
2007-12-28 |
2015-11-16 |
임팩스 라보라토리즈, 인코포레이티드 |
레보도파 방출 제어형 제제 및 이의 용도
|
EP2242485A4
(en)
*
|
2008-02-15 |
2013-05-08 |
Sun Pharma Advanced Res Co Ltd |
ORAL TABLET WITH CONTROLLED RELEASE
|
MX340249B
(es)
|
2008-08-15 |
2016-07-01 |
Depomed Inc |
Composiciones farmacéuticas retentivas gástricas para tratamiento y prevención de transtornos del sistema nervioso central (cns).
|
CN102438463A
(zh)
|
2009-01-22 |
2012-05-02 |
卡夫食品环球品牌有限责任公司 |
糖食加工
|
EP3689150A1
(en)
*
|
2009-10-08 |
2020-08-05 |
Intercontinental Great Brands LLC |
Co-extruded layered candy and gum apparatus and methods
|
WO2011071877A2
(en)
*
|
2009-12-07 |
2011-06-16 |
Mcneil-Ppc, Inc. |
Partial dip coating of dosage forms for modified release
|
US10485770B2
(en)
|
2009-12-21 |
2019-11-26 |
Aptapharma, Inc. |
Functionally-coated multilayer tablets
|
EP2550961A4
(en)
*
|
2010-03-23 |
2013-08-07 |
Lintec Corp |
SOLID PREPARATION
|
BR112016006485A2
(pt)
*
|
2013-09-27 |
2017-08-01 |
Johnson & Johnson Consumer Inc |
composições de liberação pulsátil revestidas por compressão
|
EP3782614A1
(en)
|
2013-10-07 |
2021-02-24 |
Impax Laboratories, LLC |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
US10987313B2
(en)
|
2013-10-07 |
2021-04-27 |
Impax Laboratories, Llc |
Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
|
CN103948557A
(zh)
*
|
2014-04-08 |
2014-07-30 |
闻晓光 |
一种新型控释片
|
CN107847398B
(zh)
*
|
2016-05-05 |
2019-05-07 |
南京三迭纪医药科技有限公司 |
控制释放的药物剂型
|
WO2018137686A1
(en)
*
|
2017-01-26 |
2018-08-02 |
Triastek, Inc. |
Dosage forms of controlled release at specific gastrointestinal sites
|
JP7040418B2
(ja)
*
|
2018-11-21 |
2022-03-23 |
株式会社村田製作所 |
錠剤
|
WO2022044045A1
(en)
*
|
2020-08-26 |
2022-03-03 |
Rubicon Research Private Limited |
Modified release formulations of levodopa
|